OSTEOARTICULAR SEPSIS ON EQUIPMENT in Intensive Care and Continuing Care Units in France

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

This is an ambispective observational study of patients admitted to intensive care with a diagnosis of joint prosthesis infection (mainly knee and hip prostheses). The main objective of the study is to describe the profile, care trajectories during the stay (before or after surgery) and prognosis of patients admitted to critical care with such an infection. We also aim to compare prognosis between different groups of patients sharing the same profile and care trajectory, and to assess independent risk factors associated with 2-year mortality among the study population. Finally, we will describe the microbiological and resistance profile of severe osteoarticular device infections requiring critical care admission in France. This is a descriptive and analytical observational study open to all French public and private hospitals. Patient data will be retrieved prospectively from patient source files. Only 2-year data (vital status, functional data) will be collected specifically for the study, by telephone contact with the patient or his or her support person.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patient at least 18 years old.

• Hospitalization in critical care (intensive care unit or continuing care unit) between 2018 and 2022 of at least 48 hours, with prosthetic joint infection (hip, knee or shoulder prosthesis infection) as the main or associated diagnosis.

Locations
Other Locations
France
Hôpital Lariboisière
RECRUITING
Paris
Contact Information
Primary
Benjamin SOYER, MD, Msc
benjamin.soyer@aphp.fr
+33 1 49 95 85 15
Backup
Benjamin G CHOUSTERMAN, MD, PhD
benjamin.chousterman@aphp.fr
Time Frame
Start Date: 2025-03-31
Estimated Completion Date: 2025-07-31
Participants
Target number of participants: 150
Treatments
Global cohort
All patients admitted to intensive care during the study period
Related Therapeutic Areas
Sponsors
Leads: Assistance Publique - Hôpitaux de Paris

This content was sourced from clinicaltrials.gov